BioProtect
7
0
1
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
50%
3 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Post Marketing Clinical Follow Up of the BioProtect Balloon Implant System
Role: lead
Retrospective Evaluation of Commercial Spacers in Prostate Cancer Patients
Role: lead
Prospective Evaluation of a Commercially Available Hydrogel Spacer
Role: lead
BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007
Role: lead
Retrospective Evaluation of a Commercially Available Hydrogel Spacer (BP-009)
Role: lead
Evaluation of the Safety and Efficacy of the BioProtect Balloon in Prostate Cancer Subjects Undergoing Radiotherapy
Role: lead
Pilot Study to Assess the Safety and Efficacy of BioProtect Balloon in Prostate Cancer Subjects
Role: lead
All 7 trials loaded